Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00438477 · ClinicalTrials.gov registry record · NA
Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
NCT00438477: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT00438477 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 74 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00438477, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures, such as lymphoscintigraphy using an injection under the nipple or near the tumor, may help doctors find out how far the disease has spread. PURPOSE: This clinical trial is studying two different injection methods to compare how well they find the sentinel lymph node during lymphatic mapping and sentinel lymph node biopsy in patients with invasive breast cancer.
Interventions
- PROCEDURE Lymphangiography
- DRUG Isosulfan Blue
- RADIATION Technetium Tc 99m sulfur colloid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2005-06 |
| Est. Completion | 2008-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00438477
The ClinicalTrials.gov registry entry for NCT00438477 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Lymphangiography is the first listed.
NCT00438477 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00438477 about?
NCT00438477 is a clinical study titled "Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer". RATIONALE: Diagnostic procedures, such as lymphoscintigraphy using an injection under the nipple or near the tumor, may help doctors find out how far the disease has spread. PURPOSE: This clinical trial is studying two different injection methods to compare how well they find the sentinel lymph nod...
What is the current status of trial NCT00438477?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2005-06. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00438477?
The interventions under investigation include: Lymphangiography (PROCEDURE), Isosulfan Blue (DRUG), Technetium Tc 99m sulfur colloid (RADIATION).
Who is sponsoring clinical trial NCT00438477?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.